# FDA Inspection 1217251 - BioIVT LLC - August 23, 2023

Source: https://www.keypedia.com/records/fda_inspections/bioivt-llc/1cea3536-af14-4e3d-831b-b6bfb5b38aba
Source feed: FDA_Inspections

> FDA Inspection 1217251 for BioIVT LLC on August 23, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1217251
- Company Name: BioIVT LLC
- Inspection Date: 2023-08-23
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1100353 - 2019-07-18](https://www.keypedia.com/records/fda_inspections/bioivt-llc/5c818f1e-354a-4e4c-8688-c047ab2de9a3)
- [FDA Inspection 926277 - 2015-05-14](https://www.keypedia.com/records/fda_inspections/bioivt-llc/e5da34b9-bcec-4e0d-8834-f9bbd03a5818)
- [FDA Inspection 736628 - 2011-07-28](https://www.keypedia.com/records/fda_inspections/bioivt-llc/9f680cb7-1ca5-48c3-9311-6ccfd635eafe)

Company: https://www.keypedia.com/companies/bioivt-llc/6ccbe686-dec4-4ba7-aa07-2c5f5fc83193

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d